1. Patte C, Zimmermann M, Auperin A, Reiter A. Similar results are currently observed in the LMB and BFM stdudies for B-cell Non-Hodgkin's Lymphoma and B-AL allowing future common studies. Pediatr Blood Cancer. 2010;55(5):795. abstract.
2. Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol. 2013. doi: 10.1016/j.critrevonc.2012.12.009 .
3. Kelly JL, Toothaker SR, Ciminello L, Hoelzer D, Holte H, LaCasce AS, et al. Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens. Clin Lymphoma Myeloma. 2009;9(4):307–10.
4. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012;380(9844):848–57.
5. O’Leary M, Sheaffer J, Keller F, Shu X-O, Cheson B. Lymphomas and reticuloendothelial neoplasms. In: Bleyer A, O’Leary M, Barr R, Ries LA, eds. Cancer epidemiology in older children and young adults 15–29 years of age, including SEER Incidence and Survival: 1975–2000. NIH Pub. No. 06–5767. Bethesda: National Cancer Institute; 2006. p. 25–38.